Network / Interactive Map / Entity profile
ALLOGENE THERAPEUTICS
Startup
ALLOGENE THERAPEUTICS
Description
Allogene Therapeutics develops allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies designed for cancer.
Resources
ALLOGENE THERAPEUTICS
Address
United States
Contact
info@allogene.com
Description
Allogene Therapeutics develops allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies designed for cancer.
Resources
Matchmaking
Connect with ALLOGENE THERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen

Identification of biotherapies
- Target identification
- Target validation
- Screening

Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies

Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production

Production
- Upstream processes
- Downstream processes
- Quality control

Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
TRL
Not yet on COBIOE directory?
Want to access to more data?
Want to contact this entity?